Survey of New York City Soil Uncovers Medicine-Making Microbes
News Dec 03, 2016
Researchers at The Rockefeller University have shown that the dirt beneath New York City teems with our tiny allies in the fight against disease. In soil collected from city parks, the team dug up genetic evidence of bacteria capable of producing a wide range of compounds whose potent effects might be harnessed as medicines. Their work was described November in the Proceedings of the National Academy of Sciences.
“By sequencing and analyzing genes within soil samples, we found the genetic instructions for making a wide range of natural products that have the potential to become treatments for various conditions, from cancer to bacterial or fungal infections, or that are already being used as drugs,” says senior author Sean F. Brady, the Evnin Associate Professor and head of Rockefeller’s Laboratory of Genetically Encoded Small Molecules. “The sheer diversity we saw suggests there are many more potentially valuable compounds out there awaiting discovery—even in a place as mundane as urban soil,” he adds.
In their invisible battles against one another and against other organisms, microbes have developed a wealth of chemical weapons that have been turned into medicines capable of myriad feats, from fighting off viruses to killing tumor cells. Because soil is crammed with competing microbes, it is a rich source of such microbe-derived medicines. However, only a fraction of soil bacteria can be grown in the lab, severely limiting scientists’ ability to exploit them. Brady’s lab avoids this problem by looking directly at the bacterial DNA in soil. Within these sequences, the researchers can identify the instructions for making molecules that interest them.
The research on New York City soil was a collaboration with the nonprofit Natural Areas Conservancy, whose scientists made sure the 275 samples came from a variety of ecosystems within New York City’s park system. With assistance from the conservancy, five high school students participating in Rockefeller’s Science Outreach Program collected small amounts of topsoil. These went to Barnard College where the DNA was isolated, then on to Rockefeller where scientists decoded the precise genetic sequences it contained. The researchers then compared their samples to those from known nonribosomal peptides and polyketides, two families of compounds to which many therapeutic molecules previously isolated from bacteria belong.
As it turns out, the city’s diversity extends down into its soil. For instance, a single sample from Prospect Park in Brooklyn harbored genes that likely encode 25 molecules that have been studied for potential use as antibiotics and other types of medicines. Meanwhile, a set of 11 representative compounds discovered elsewhere around the world—such as the antibiotic erythromycin from the Philippines and the antifungal agent natamycin from South Africa—are encoded by genes that were observed within the city parks’ soil. The most important finding, say the scientists, is the abundance of unfamiliar genes.
“Less than one percent of molecule-encoding sequences matched up to the known genes to which we compared them,” says first author Zachary Charlop-Powers, a postdoc in Brady’s lab. “Similar efforts in soil collected elsewhere have also shown that novel molecule-encoding sequences vastly outnumber those we recognize. This suggests there are many as yet-unidentified genes out there, and among these, some are likely to have potentially useful biological activity.”
For Brady, the genetic riches of city soil suggest it’s time to shift the strategy for identifying new compounds. “Throughout the history of the field, there has been this idea that one travels to remote parts of the world to collect strange bacteria. But those environments are fragile and disappearing,” says Brady, who is also a Howard Hughes Medical Institute Early Career Scientist. “Meanwhile, we’re finding that by using modern sequencing approaches, it’s possible to turn up all of the same potentially useful molecules in our own backyards.” Brady’s lab continues to examine soil samples from around the United States for genes encoding potentially useful compounds.
Source: Story from Rockefeller University. Please note: The content above may have been edited to ensure it is in keeping with Technology Networks' style and length guidelines.
Reference: Charlop-Powers, Z., Pregitzer, C. C., Lemetre, C., Ternei, M. A., Maniko, J., Hover, B. M., . . . Brady, S. F. (2016). Urban park soil microbiomes are a rich reservoir of natural product biosynthetic diversity. Proceedings of the National Academy of Sciences, 201615581. doi:10.1073/pnas.1615581113
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Synthesis of Drug-Like Molecules Simplified Using New Cross-Coupling MethodNews
Researchers have designed a new molecule-building method. The technique, described recently in the journal Science, paves the way toward other new chemical reactions and facilitates the synthesis of pharmaceutically-relevant molecules.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
10th International Conference on Mass Spectrometry and Chromatography
Oct 08 - Oct 09, 2018